Clinical Trials

Advancing Cancer Care Through Clinical Trials

Clinical trials are the foundation of medical progress, driving the discovery of new treatments and improving patient outcomes. Highlands Oncology has been actively involved in clinical research for more than 26 years, conducting numerous studies in both oncology and hematology.
Through these trials, new experimental medications—or innovative ways of using existing therapies—are compared to current standards of care. This process helps advance cancer treatment for patients locally and around the world.
Each clinical trial follows strict eligibility criteria designed to ensure patient safety. Clinical trials typically progress through four phases of development:

• Phase I: Determines safe dosage levels and evaluates safety
• Phase II: Further assesses safety and begins to evaluate effectiveness
• Phase III: Compares the new therapy to standard treatments
• Phase IV: Studies the long-term safety and effectiveness of FDA-approved treatments

Highlands Oncology is proud to be the only community-based Phase I oncology clinical trial center in Arkansas, offering patients access to the newest and most innovative cancer therapies close to home.

Cancer research is constantly evolving, and new treatments emerge every year. Our Research Department ensures that Highlands Oncology remains at the forefront of medical innovation through continued participation in clinical trials.
We are committed to providing every patient with as many treatment options as possible. Only you and your physician can decide if a clinical trial is right for you. To explore our currently enrolling studies, please visit our Clinical Trials page. For more information about clinical trials in general, visit clinicaltrials.gov.